Stay updated with breaking news from Membrane Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 4,430,000 shares, a drop of 7.3% from the September 30th total of 4,780,000 shares. Based on an average daily volume of 349,000 shares, […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report)’s share price was down 4.6% during trading on Friday . The stock traded as low as $20.45 and last traded at $20.55. Approximately 49,104 shares traded hands during trading, a decline of 83% from the average daily volume of 284,889 shares. The stock had previously closed at […]
Several analysts have recently updated their ratings and price targets for Bicycle Therapeutics (NASDAQ: BCYC): 9/12/2023 – Bicycle Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $44.00 price target on the stock. 9/12/2023 – Bicycle Therapeutics had its “buy” rating reaffirmed by analysts at Needham & Company […]
B. Riley upgraded shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) from a neutral rating to a buy rating in a report published on Monday, MarketBeat.com reports. B. Riley currently has $33.00 price objective on the stock. Several other analysts have also recently commented on BCYC. HC Wainwright reiterated a buy rating and set a […]